A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This study is a randomized, double-blind, multicenter, phase Ⅲ clinical study to compare the clinical efficacy and safety of Docetaxel for Injection (Albumin Bound) in combination with best supportive care versus placebo in combination with best supportive care in participants with pancreatic cancer who have received gemcitabine-containing and fluorouracil-containing regimens.
Epistemonikos ID: 2bae048b76aa9e95c74c44236b7dee7f4b40b07a
First added on: Apr 17, 2025